A 35-Year-Old Man Presenting Sleep-Related Painful Erections (Erpes): A Case Report and Review of Literature

Abstract

Introduction: Erectile episodes occurring in the night time are considered normal and are usually related to the REM sleep. Spontaneous painful erections are unusual but they can have a great impact in the patient’s quality of sleep and, for consequence, quality of life. Report: We present a patient who has been presenting painful erections which wake him up almost every night. We discuss the workup and treatment offered to the patient, as well as the short-time response and two months follow-up. Discussion: Although studies still do not explain this relationship, nocturnal erections occur only during rapid eye movement (REM) sleep, which can be confirmed by polysomnography accompanied by Nocturnal Penile Tumescence testing or RigiScan test. However, diagnosis can be established based exclusively on clinical aspects. Based on all literature reviewed, the initial treatment should safely consist in improvement in sleep architecture and pelvis muscles relaxation. Conclusion: After the first suspicion, polysomnography with rigidity measurements of nocturnal erections should be considered although clinical diagnosis and therapeutic test may be acceptable. The management we suggest is usually effective, well tolerated and sustained.

Share and Cite:

D. de Freitas G. Soares and E. Luis Rhoden, "A 35-Year-Old Man Presenting Sleep-Related Painful Erections (Erpes): A Case Report and Review of Literature," Advances in Sexual Medicine, Vol. 4 No. 1, 2014, pp. 6-10. doi: 10.4236/asm.2014.41002.

1. Introduction

Pleomorphic Hyalinizing Angiectatic Tumor (PHAT), first described by Smith et al. in 1996 [1], is a rare lowgrade mesenchymal neoplasm that most often arises in the suprafascial subcutaneous areas of the extremities, and less frequently in the musculature of the limbs. Fewer than 100 cases have been described in the literature. Clinical features are slow-growing, non-metastasizing, locally infiltrative border, and borderline malignancy with a high rate of local recurrence. PHAT describes a heterogeneous group of neoplasms of undetermined tumorigenesis, characterized by clusters of ectatic, fibrinlined, and thin-walled vessels that are surrounded by spindled or pleomorphic neoplastic cells with variable inflammatory components. The neoplastic cells frequently have intracytoplasmic hemosiderin granules, intranuclear inclusions, and low mitotic activity [2-5]. Based only on the morphological findings of histopathology, the biological potential of the tumor is indeterminate. The level of fluorodeoxyglucose (FDG) uptake during positron emission tomography (FDG-PET) has been used as an in vivo method for identifying tumor metabolism and biological activity, as well as a prognostic indicator for malignancy. However, FDG uptake in PHAT has not been adequately described in the literature.

2. Case Report

62-yrs-old male suffered from sigmoid colon cancer 18 years ago (aged 44, in 1995). A left inguinal hernioplasty with mesh support was performed simultaneously during the surgical resection of the tumor. Afterward, he received 5-FU adjuvant chemotherapy without local radiotherapy. A FDG-PET follow-up examination was performed in 2004, during which a focal area in the left inguinal region adjacent to the urinary bladder displayed increased FDG activity (Figures 1(a1) and (b1)). The maximum standard uptake value (SUVm) of the lesion was 3.2. Magnetic resonance imaging (MRI) showed a tumor in the corresponding region (Figure 2(a1) through Figure 2(a4)). A fixed, firm mass was detected by manual palpation of the left inguinal area. No other symp-

Figure 1. Fluorodeoxyglucose uptake during positron emission tomography (FDG-PET) imaging of the pleomorphic hyalinizing angiectatic tumor (PHAT). FDG-PET was performed in September 2004, and revealed a focal area with increased activity in the left inguinal region (a1). The maximum standard uptake value (SUVm) of the lesion was 3.2. Follow-up FDG-PET in March 2006 (a2) and December 2007 (a3) showed similar findings, with SUVm values of 4.1 and 4.2, respectively. Corresponding images of a transaxial section are shown, from top to bottom (b1, b2 and b3). In addition, the SUVm of the lesion during 3-hr delayed-phase imaging showed no significant changes, compared with the early-phase images. Arrows indicate the lesion.

Figure 2. MRI was performed in September 2004, and showed a lobulated soft tissue mass measuring approximately 3.4 × 3.0 cm in the largest dimension that was located interposition within lower portion of left rectus abdominis muscle. The mass exhibited hypo-intensity on T1WI (a1), and the heterogeneity of the mass mildly increased in intensity on T2WI (a2) and with high gadolinium irregular margin enhancement (a3). A mass compression effect on the adjacent urinary bladder and left inguinal sac was demonstrated (a4) in the coronal view shown. In March 2012, the mass showed increased size and changes in contour (b).

toms or signs were observed. The mass was considered an inflammatory pseudotumor resulting from the hernioplasty mesh because the SUVm of FDG was not high enough to indicate malignancy. This diagnosis was further supported by similar FDG-PET findings in subsequent follow-up examinations in 2006 and 2007 (Figures 1(a2) and (b2)) and (Figures 1(a3) and (b3)), and the follow-up MRI results that showed the size and the feature of the mass had remained unchanged (data not shown). No further signs or symptoms were observed during the remainder of the 17-year follow-up period (1995-2012). Bilateral hernioplasty was received on March 2012 because the symptoms of inguinal hernia had become exaggerated. During the accompanying MRI examination, changes in the size and contour of the inguinal lesion were noted (Figure 2(b)). Fordyce angiokeratoma was also diagnosed based on a number of purple papules on the scrotum, which is often associated with thrombophlebitis of the scrotum, varicocele, and inguinal hernia [6]. During laparotomy, a non-granulomatous tumor was surgically resected from the left rectus abdominis muscle. Gross examination of the tumor showed that it was well-circumscribed, lobulated, solid, and firm (Figure 3(a)), and the histopathology indicated that it was PHAT (Figures 3(b) and (c)). Up to now, he has been robust during one and half years of follow-up.

3. Discussion

FDG-PET is a novel modality for metabolic imaging in clinical oncology. It was first used to differentiate benign and malignant lung tumors. However, the specificity of FDG-PET for estimating malignancy remains uncertain. Infection, inflammation, and certain benign pathological variants can mimic the FDG-uptake properties observed in malignancy, contributing to the misinterpretation of FDG-PET images [7]. Quantitative SUVm analysis of tumors is often recommended to discriminate between benign and malignant masses. However, cutoff values for malignancy have not been well defined, and considerable overlap between the SUVm of benign and malignant tumors has been observed. We previously reported the FDG-PET characteristics of three types of benign lesions. These consisted of an angiolipoma in the lower abdominal wall [8], a neurofibroma arising from para-spinal soft tissue [9], and a granuloma formed as a post-opera-

Figure 3. Gross examination and histology of the intramuscular tumor. (a) Grossly, the tumor was encapsulated, wellcircumscribed, lobulated, solid and firm, and no adjacent organ invasion was observed. Microscopic examination (b) and (c) showed hypocellular spinal-cell proliferation, prominent nuclear pleomorphism, low mitotic figure, and ectatic, fibrin-lined, and hyalinized thin-walled with some thrombosed vessels. Weakly positive EMA staining was noted in the immunohistochemical studies.

tive foreign body in the abdominal cavity [10]. We posited that inflammation, fibrin thrombi, and an ectatic, congestive vascular space had led to an increased accumulation of FDG (SUVm = 3.2) within the angiolipoma. The proliferative spindle cells of the neurofibroma and the intense inflammation associated with the granuloma were considered to have contributed to the increased FDG uptake (SUVm = 4.6 and 10.8, respectively) in those cases. Only one previous case of PHAT had been found at our institution [3], and that tumor had displayed mild FDG uptake (SUVm = 1.4) during FDG-PET examination. In PHAT, we propose that FDG accumulation in the ectatic vessel, increased uptake of the pleomorphic cells and/or associated inflammatory cells, and increased permeability of the stroma lead to the imaging feature. Whether high SUVm represents sarcomatous transformation of soft tissue neoplasms requires further correlation analysis with histopathological features and clinical outcomes. Folpe and Weiss proposed that PHAT is a neoplasm, rather than a reactive lesion [4]. The occurrence of PHAT in the inguinal area is rare [11], and the tumorigenesis in my case was unclear. However, the reaction of the tissues to surgical manipulation and/or the surgical mesh warrants consideration. The diagnosis of PHAT using MRI alone is unreliable. The features are variable, and notice should be taken when encountering an enhancing subcutaneous tumor with ill-defined margins [12].

NOTES

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] I. Karacan, P. J. Salis, J. I. Thornby and R. L. Williams, “The Ontogeny of Nocturnal Penile Tumescence,” Waking Sleeping, Vol. 1, 1976, pp. 27-44.
[2] I. Karacan, R. L. Williams, J. I. Thornby and P. J. Thalis, “Sleep Related Penile Tumescence as a Function of Age,” American Journal of Psychiatry, Vol. 132, 1975, p. 932.
[3] C. Iber, S. Ancoli-Israel, A. Chesson and S. F. Quan, “The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specification,” American Academy of Sleep Medicine, Westchester, 2007.
[4] J. Bancroft, “The Endocrinology of Sexual Arousal,” Journal of Endocrinology, Vol. 186, No. 3, 2005, pp. 411-427.
[5] M. Hirshkowit, C. A. Moore, C. R. Hamilton, et al., “Polysomnography of Adults and Elderly: Sleep Architecture, Respiration and Leg Movements,” Journal of Clinical Neurophysiology, Vol. 9, No. 1, 1992, p. 56. http://dx.doi.org/10.1097/00004691-199201000-00006
[6] G. Karsenty, E. Werth, P. A. Knapp, A. Curt, B. Schurch and C. L. Bassetti, “Sleep-Related Painful Erections,” Nature Clinical Practice Urology, Vol. 2, No. 5, 2005, pp. 256-260.
http://dx.doi.org/10.1038/ncpuro0184
[7] M. J. Thorpy, “Classification of Sleep Disorders,” Journal of Clinical Neurophysiology, Vol. 7, No. 1, 1990, pp. 67-81. http://dx.doi.org/10.1097/00004691-199001000-00006
[8] I Karacan, “Painful Nocturnal Penile Erections,” The Journal of the American Medical Association, Vol. 215, 1971, p. 1831.
[9] U. Calvet, “Painful Nocturnal Erection,” Sleep Medicine Reviews, Vol. 3, No. 1, 1999, pp. 47-57.
http://dx.doi.org/10.1016/S1087-0792(99)90013-8
[10] A. Steiger and O. Benkert, “Examination and Treatment of Sleep Related Painful Erections. A Case Report,” Sleep Medicine Reviews, Vol. 18, No. 3, 1989, 263-267. http://dx.doi.org/10.1007/BF01543200
[11] L. Ferini-Strambi et al., “Sleep-Related Painful Erections: Clinical and Polysomnographic Features,” Journal of Sleep Research, Vol. 5, No. 3, 1996, pp. 195-197. http://dx.doi.org/10.1007/BF01543200
[12] B. J. Matthews and M. B. Crutchfield, “Painful Nocturnal Penile Erections Associated with Rapid Eye Movement Sleep,” Sleep, Vol. 10, No. 2, 1987, pp. 184-187.
[13] M. F. van Driel, J. J. Beck, H. W. Elzevier, J. H. van der Hoeven and J. M. Nijman, “The Treatment of Sleep-Related Painful Erections,” The Journal of Sexual Medicine, Vol. 5, No. 4, 2008, pp. 909-918. http://dx.doi.org/10.1111/j.1743-6109.2007.00645.x
[14] A. Steiger and O. Benkert, “Examination and Treatment of Sleep Related Painful Erections. A Case Report,” A Archives of Sexual Behavior, Vol. 18, No. 3, 1989, 263-267.
http://dx.doi.org/10.1007/BF01543200
[15] A. V. Cordioli e cols, Psicofármacos, Artmed, 3th ed., 2005.
[16] K. F. Rourke, A. H. Fischler and G. H. Jordan, “Treatment of Recurrent Idiopathic Priapism with Oral Baclofen,” The Journal of Urology, Vol. 168, No. 6, 2002, pp. 2552-2553.
http://dx.doi.org/10.1016/S0022-5347(05)64201-2

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.